Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation

BACKGROUND: Significant advances in the molecular profiling of gliomas, led the 2016 World Health Organization (WHO) Classification to include, for the first-time, molecular biomarkers in glioma diagnosis: IDH mutations and 1p/19q codeletion. Here, we evaluated the effect of this new classification...

Descripción completa

Detalles Bibliográficos
Autores principales: Brito, Cheila, Azevedo, Ana, Esteves, Susana, Marques, Ana Rita, Martins, Carmo, Costa, Ilda, Mafra, Manuela, Bravo Marques, José M., Roque, Lúcia, Pojo, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798410/
https://www.ncbi.nlm.nih.gov/pubmed/31623593
http://dx.doi.org/10.1186/s12885-019-6177-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798410/
https://www.ncbi.nlm.nih.gov/pubmed/31623593
http://dx.doi.org/10.1186/s12885-019-6177-0

Ejemplares similares